Overview

Trial to Investigate GZ21T in Healthy Volunteers

Status:
RECRUITING

Trial end date:
2025-03-31

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomised, placebo-controlled trial designed to evaluate safety, tolerability, and pharmacokinetics (PK) after topical administration of single ascending doses of GZ21T in healthy volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

Genzada Pharmaceuticals USA, Inc.

Collaborator:

CTC Clinical Trial Consultants AB